EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  1. Smolen, J.S.
  2. Landewé, R.
  3. Bijlsma, J.
  4. Burmester, G.
  5. Chatzidionysiou, K.
  6. Dougados, M.
  7. Nam, J.
  8. Ramiro, S.
  9. Voshaar, M.
  10. Van Vollenhoven, R.
  11. Aletaha, D.
  12. Aringer, M.
  13. Boers, M.
  14. Buckley, C.D.
  15. Buttgereit, F.
  16. Bykerk, V.
  17. Cardiel, M.
  18. Combe, B.
  19. Cutolo, M.
  20. Van Eijk-Hustings, Y.
  21. Emery, P.
  22. Finckh, A.
  23. Gabay, C.
  24. Gomez-Reino, J.
  25. Gossec, L.
  26. Gottenberg, J.-E.
  27. Hazes, J.M.W.
  28. Huizinga, T.
  29. Jani, M.
  30. Karateev, D.
  31. Kouloumas, M.
  32. Kvien, T.
  33. Li, Z.
  34. Mariette, X.
  35. McInnes, I.
  36. Mysler, E.
  37. Nash, P.
  38. Pavelka, K.
  39. Poór, G.
  40. Richez, C.
  41. Van Riel, P.
  42. Rubbert-Roth, A.
  43. Saag, K.
  44. Da Silva, J.
  45. Stamm, T.
  46. Takeuchi, T.
  47. Westhovens, R.
  48. De Wit, M.
  49. Van Der Heijde, D.
  50. Show all authors +
Journal:
Annals of the Rheumatic Diseases

ISSN: 1468-2060,  0003-4967

Year of publication: 2017

Volume: 76

Issue: 6

Pages: 960-977

Type: Article

DOI: 10.1136/ANNRHEUMDIS-2016-210715 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus